PAUL LAURENCE E 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Jun 5, 2012
Insider Transaction Report
Form 4
PAUL LAURENCE E
Director
Transactions
- Purchase
Common Shares, no par value
2012-06-01$46.85/sh+4,300$201,455→ 60,459 total
Footnotes (1)
- [F1]This number represents common shares purchased by the director, as well as other outstanding equity awards that were previously reported in Table 1.